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Abstract Mitochondrial quality control refers to the coordinat-
ed cellular systems involved in maintaining a population of
healthy mitochondria. In addition to mitochondrial protein
chaperones (Hsp10, Hsp60, and others) and proteases (Lon,
AAA proteases) needed for refolding or degrading individual
proteins, mitochondrial integrity is maintained through the reg-
ulation of protein import via the TOM/TIM complex and pro-
tein redistribution across the network via fusion and fission and
through mitophagy and biogenesis, key determinants of mito-
chondrial turnover. A growing number of studies point to the
importance of mitochondrial dynamics (fusion/fission) and mi-
tochondrial autophagy in the heart. Mitochondrial biogenesis
must keep pace with mitophagy in order to maintain a stable
number of mitochondria. In this review, we will discuss the use
of MitoTimer as a tool to monitor mitochondrial turnover.
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Mitochondrial turnover
Mitochondria have tissue-specific rates of turnover. For ex-
ample, in the mouse heart, mitochondria turn over with a half-
life of 14 days [1], but in the liver, the half-life is 2–4 days [2,
3]. Selective mitochondrial autophagy, or mitophagy, elimi-
nates damaged and dysfunctional mitochondria [4] and is
closely linked to mitochondrial biogenesis, which permits
replacement of mitochondria (or synthesis of components
and their insertion into the remaining functional mitochondria).
Rat cardiomyocytes have ~10,000 mitochondria per cell [5–9];
this suggests that under resting conditions, one mitochondrial
unit per cell is replaced every 4min (assuming turnover proceeds
at a constant rate). Mitochondria comprise one third of the
volume of the heart and under normal conditions are responsible
for 93% of ATP production (glycolysis is responsible for 3–7%,
but this may rise considerably during ischemia) [10]. However,
mitochondria are not producing ATP at maximal rates all of the
time, rather they are heterogeneous [11]: somemitochondriamay
be producing ATP at high rates while others may be relatively
inefficient or quiescent or producing significant amounts of
reactive oxygen species (ROS). Mitochondria routinely sustain
oxidative damage as a by-product of oxidative phosphorylation.
However, this is ordinarily handled by targeted protein quality
control (Lon protease and other AAA proteases) [12] and by
exchange of components during fusion followed by fission [1,
11]. Asymmetric fission allows for segregation of dysfunctional
components into one daughter mitochondrion that can be re-
moved by autophagy [11]. A number of enzymes involved in
oxidative phosphorylation (OX-PHOS) are expressed with diur-
nal variation [13], suggesting that mitochondrial regeneration is
regulated by the circadian cycle, and further implies that mito-
chondrial elimination might be similarly regulated. This seems
likely given that a period of fasting occurs during sleep; therefore,
waves of mitochondrial elimination may alternate with regener-
ation on a daily basis, with 3–4 % of the mitochondrial mass (or
population) being replaced each day [3]. However, this may be
much higher: in HL-1 cells subjected to serum and amino acid
starvation (glucose present) for 3.5 h, the number of mitochon-
dria is reduced by 70 % [14].
Benefits of mitophagy
Previous work by our lab has demonstrated that Parkin-
dependent mitophagy is essential for the protective effect of
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ischemic preconditioning [15]. The selection of mitochondria
for elimination by autophagy is related to low membrane
potential and possibly other factors such as ROS production
[16]. Since mitochondria with low membrane potential will
not produce much ATP, their selective elimination may not
have a noticeable impact on cellular ATP levels. In fact,
elimination of depolarized mitochondria could increase cellu-
lar ATP by reducing the futile hydrolysis of ATP in an effort to
restore mitochondrial membrane potential. Furthermore, elim-
inating dysfunctional mitochondria might attenuate ROS pro-
duction, and the remaining mitochondrial population might
exhibit better calcium homeostasis and greater resistance to
MPTP induction. In rats subjected to 50 % caloric restriction
for 1 week followed by 1 week of refeeding, the hepatic
mitochondria were shown to be more efficient, as reflected
by higher state 3 mitochondrial respiratory capacity and in-
creased superoxide dismutase activity [17].
Failure of mitochondrial quality control is accompanied by
progressively lower membrane potential, decreasing cellular
ATP levels, and increased ROS production [18]. Complex I
and aldehyde dehydrogenase 2 (ALDH2) are well known to
be vulnerable to oxidative damage, and specific aldehyde
modifications are detected in mitochondria from hearts after
acute oxidative stress [19, 20]. Cardioprotection reduces the
abundance of these modifications, and we suggest this is
mediated in part by mitophagy and biogenesis.
Mitophagy is balanced by biogenesis
In order to maintain cellular homeostasis, elimination of mi-
tochondria must be balanced by their replacement with newer,
more efficient mitochondria. The transcriptional co-activator
peroxisome proliferator-activated receptor gamma co-
activator 1-alpha (PGC-1α) is the master regulator of mito-
chondrial biogenesis. Interestingly, many of the same regula-
tory elements found in the promoters of OX-PHOS genes are
also found in the promoters of autophagy genes, suggesting
coordinate regulation (L van der Stap, KD Finley, and RA
Gottlieb, unpublished data). PGC-1α also regulates expres-
sion of TFEB, the key transcriptional regulator of autophagy
and lysosomal biogenesis. The peroxisome proliferator-
activated receptor gamma (PPARγ) in tandem with the
retinoic acid receptor (RXR) regulates pathways of fatty acid
oxidation for both mitochondria and peroxisomes. Free fatty
acids, clofibrate, and thiazolidinediones are ligands for
PPARγ and st imulate mitochondrial biogenesis .
Mitochondrial biogenesis is controlled by the PPARγ coacti-
vator (PGC) family of transcriptional coactivators, most im-
portantly PGC-1α, PGC-1β, and the PGC-related coactivator
PRC. PGC-1α works in tandem with nuclear respiratory
factor 2 (NRF-2) to co-activate NRF-1 [21]. The NRFs direct
the transcription of nuclear-encoded mitochondrial proteins,
the mitochondrial protein import machinery, and co-factors
required for assembly of the respiratory chain complexes, as
well as the regulatory factors required for mitochondrial DNA
transcription and translation, most importantly mitochondrial
transcription factor A (Tfam). Tfam is important not only for
mitochondrial gene transcription but also for maintenance of
mitochondrial DNA (mtDNA) copy number [22].
Overexpression of PGC-1α is sufficient to drive mitochondri-
al biogenesis [23]. Acetylation of PGC-1α suppresses its
transcriptional co-activator activity and can therefore limit
mitochondrial biogenesis despite high levels of protein.
Therefore, an important regulator of mitochondrial biogenesis
is the histone deacetylase sirtuin 1 (Sirt1) which can serve to
activate autophagy as well as PGC-1α and mitochondrial
biogenesis [24, 25]. Another linkage between mitophagy
and biogenesis is PARIS (also known as ZNF746), a substrate
of Parkin that functions as a transcriptional repressor of PGC-
1α [26].
Additional pathways converge on mitochondrial quality
control
Mitochondria possess machinery for responding to an imbal-
ance between imported nuclear-encoded proteins and
mitochondrial-encoded proteins, known as the mitochondrial
unfolded protein response (UPRmt). The correct stoichiome-
try of OX-PHOS subunits is essential for assembly of func-
tional respiratory complexes. Excess or unincorporated sub-
units are degraded to short peptides by matrix proteases of the
AAA+ family (ATPases associated with a variety of cellular
activities); Lon protease is responsible for the largest share of
intramitochondrial protein degradation. In Caenorhabditis
elegans, the peptide fragments generated by the related prote-
ase ClpP are extruded into the cytosol through the transporter
Haf1 [27]. The mammalian homolog is thought to be
ABCme10, and the extruded peptides are recognized by tran-
scription factors CHOP, C/EBPβ, and cJun/AP1, which direct
the expression of mitochondrial chaperone hsp60 and prote-
ases ClpP, Yme1L1, and MPPβ. Upregulation of these factors
reduces protein aggregation in the mitochondrial matrix.
Additional proteins upregulated in the UPRmt include
Tim17A, NDUFB2, and EndoG, but not ER stress proteins
Bip, Grp94, calreticulin, or calnexin [28]. PKR (double-
stranded RNA-activated protein kinase) phosphorylates
eIF2α and cJun, with the resulting suppression of translation
and import of nuclear-encoded mitochondrial proteins [29].
There is almost nothing known about the significance of the
UPRmt in the mammalian heart or its connection to
mitophagy and mitochondrial biogenesis. However, agents
such as chloramphenicol and rapamycin, which induce
mitophagy/autophagy, are also reported to be potent inducers
of UPRmt [30]. How the UPRmt may affect MitoTimer
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protein turnover and whether the overexpression of
MitoTimer affects the UPRmt are unknown but may need to
be considered when interpreting results.
Fluorescence properties of MitoTimer
Recent advances in assessing mitochondrial turnover include
the analysis of the half-lives of mitochondrial proteins using
mass spectrometry analysis and deuterium labeling [3], mito-
Keima, which can report on mitochondria delivered to the
lysosome [31], and MitoTimer, a fluorescent protein that can
be used to monitor mitochondrial turnover [32–34]. Kim et al.
demonstrated that deuterium labeling coupled with gas
chromatography-mass spectrometry can reveal differential
turnover rates of mitochondrial proteins on a proteome-wide
level [3]. This level of analysis of mitochondrial turnover rate
is highly informative in whole organs but is not suitable for
analysis of mitochondrial turnover on a level of discrete
mitochondria. Likewise, while mito-Keima is a useful tool in
quantitative assessment of single mitophagic events and al-
lows for monitoring the rate of mitophagy in cells, it does not
allow for monitoring of mitochondrial biogenesis. The major
advantage provided by MitoTimer is that it allows for the
monitoring of mitochondrial turnover and protein import
(with resolution ranging from whole tissues down to individ-
ual mitochondria). Timer is a fluorescent protein developed by
Terskikh as a mutant of DsRed [35]. Timer molecules transi-
tion from green fluorescence to a more stable red conforma-
tion over a span of 48 h [Fig. 1]. Timer or fusion protein
derivatives have been used to monitor various processes in-
cluding gene expression, intracellular protein recycling, cell
survival, and the kinetics of viral infection [36–39]. For the
purpose of tracking mitochondrial turnover, a useful approach
is to express MitoTimer under the control of a tetracycline
response element (TRE) such as pTRE-tight [33] in conjunc-
tion with the reverse tetracycline transactivator (rtTA).
Synchronized expression of MitoTimer is achieved by
Fig. 1 Maturation of MitoTimer in C2C12 cells. Cells stably transfected
with rtTA and pTRE-tight-MitoTimer were exposed to doxycycline for
1 h followed bymedia exchange, then imaged at the indicated times. Each
large panel shows the merged image while the insets show the individual
red and green channels. Synchronized maturation of MitoTimer is
evident
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inducing expression for a brief period of time with addition of
doxycycline (Dox) pulse, followed by removal of any residual
Dox (chase). The protein can be monitored as it matures from
green to red over 48 h, and it is retained in the mitochondria
for a number of days (presumably corresponding to a mito-
chondrial half-life). A second Dox pulse can be used to induce
another round of expression, which is readily evident as green
MitoTimer [Fig. 2 and schematic shown in Fig. 3]. MitoTimer
matures within 48 h, a rate which parallels mitochondrial
turnover in the liver, but considerably faster than turnover
rates in the heart. Thus in tissues with slow mitochondrial
turnover, the presence of red mitochondria after a brief induc-
tionwith doxycycline cannot allow one to distinguish between
mitochondria that imported MitoTimer 2 days ago and mito-
chondria that imported the protein 1 or 2 weeks ago. To
examine mitophagy, one must monitor the rate of disappear-
ance of (red) MitoTimer, but in dividing cells (even stably
transfected cells), one cannot distinguish between dilution of
the existing fluorescent protein due to cell division and loss of
protein through mitophagy. Thus monitoring basal rates of
mitochondrial turnover in immortalized cells may be difficult.
However, MitoTimer can be used tomonitor mitophagy that is
acutely upregulated in response to a stressor. Similar chal-
lenges and limitations exist with monitoring mitochondrial
biogenesis, but these can be partially overcome by using a
second pulse of doxycycline before or during the intervention
that is proposed to induce biogenesis. A diagram of the typical
two-pulse labeling protocol is shown in Fig. 3.While a second
doxycycline addition triggers a rather small amount of
MitoTimer incorporation under basal conditions (probably
3–4%, corresponding to the net turnover rate), an intervention
that triggers biogenesis will result in a much larger incorpo-
ration of newly synthesizedMitoTimer. Given that MitoTimer
is under the control of the artificial TRE-tight promoter, the
differential protein translation and import under basal
and stimulated conditions is likely due to posttranscrip-
tional control through the native cox8 mitochondrial
targeting sequence added to Timer [40]. Finally, it is
possible to gain insight into the relative equilibrium of
mitophagy and biogenesis under conditions of constitu-
tively expressed MitoTimer, where a change in the red
to green ratio reflects a shift in the equilibrium.
Specific considerations and protocols for usingMitoTimer
When utilizing MitoTimer to monitor mitochondrial turnover,
several factors need to be taken into account. Timer
maturation rate has previously been shown as independent
of protein concentration, ionic strength, and a wide range of
Fig. 2 Protein import in the mitochondrial network is spatially
inhomogeneous. A field of C2C12 cells exposed to doxycycline
continuously for 24 h is shown. Rectangles outline areas that are
enlarged at right; arrows indicate regions of the mitochondrial network
which contain green MitoTimer (newly synthesized and imported) but
lack mature (red) MitoTimer
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biological pH values [35]. In our studies with MitoTimer, we
have found that the maturation rate was, however, accelerated
during live fluorescence imaging of the cells. When fixed in
4 % paraformaldehyde, MitoTimer retains the conformation it
was in at the time of fixation, thus permitting prolonged
imaging of the cells. Furthermore, depending on the fluores-
cent microscope used in the experiments, filter sets may need
to be optimized in order to detect the green signal of
MitoTimer. For example, in our previous studies, we utilized
a Nikon (TE300, Nikon, Melville, NY) microscope equipped
with a cooled CCD camera (Orca-ER, Hamamatsu,
Bridgewater, NJ) and automated excitation emission filter
wheels controlled by a Lambda 10–2 (Sutter instruments)
operated by MetaMorph Version 6.2r (Molecular Devices);
in order to maximize the MitoTimer signal, we used a triple-
cube Chroma 61002-triple emitter 61002, with the added
green emission filter Chroma 233755 D520–40 m (midpoint
520, emission 500–540) and the red emission filter Chroma
221379D605–55 (midpoint 605, emission 578–632). It is also
important to make sure that threshold levels used in collecting
the images from MitoTimer cells remain the same throughout
the time course experiment. Inducible expression of
MitoTimer is a useful approach in experiments utilizing cell
lines, as time-restricted induction can provide insights into
mitochondrial dynamics and subpopulation. Inducible expres-
sion in a stably transfected cell line also avoids the effect of
leaky plasmid promoters, heterogeneous protein expression
intrinsic to transient transfection, and the abnormal
accumulation of messenger RNA (mRNA), all of which may
mask the visualization of MitoTimer maturation in discrete
mitochondria. Constitutive expression of MitoTimer can,
however, be informative in in vivo experiments, as demon-
strated by Laker et al. [32]. In this context, mitochondrial
dynamics and import rates are much more heterogeneous than
those observed in immortalized tumor-derived cell lines (es-
pecially if expressed under tissue-specific promoters), and a
shift in the abundance of newly expressed vs. mature
MitoTimer can be used to reveal changes in the rate of mito-
chondrial turnover (the balance of biogenesis and mitophagy).
In our work, we utilized the well-characterized tetracycline
(Tet)-On inducible expression systemwith a brief doxycycline
(Dox) pulse in order to synchronize the uptake of newly
synthesized MitoTimer by the mitochondria. Although this
system allows for conditional expression, it still has the draw-
back of requiring transient transfection with two plasmids and
can be unwieldy given the need to transfect, induce expres-
sion, and monitor maturation of MitoTimer during a particular
intervention. To solve this problem, we found that the best
level of control in the system could be achieved by using
retroviral transfer vectors to express the reverse Tet
transactivator and MitoTimer under the control of the Tet
responsive elements, which we used to establish stable cell
lines derived from the C2C12 skeletal muscle myoblast cell
line and the murine atrial cardiomyocyte HL-1 cell line. We
further improved the control of the system using fluorescence-
activated cell sorting to sort first for cells that were negative
2h after dox #2 with minimal biogenesis 6-12h after dox #2 with minimal biogenesis
dox pulse #1    6hr       12hr      24hr                     48hr and longer                  dox pulse #2
2h after dox #2 with active biogenesis 6-12h after dox #2 with active biogenesis
Fig. 3 Schematic of two-pulseDox induction ofMitoTimer. Dox is added to
media for 2 h, then washed out, andMitoTimer is allowed to mature for 48 h,
after which a second pulse of Dox is given in the presence or absence of an
agent to stimulate mitochondrial biogenesis. Cells are imaged a few hours
later. Under conditions of active mitochondrial biogenesis, more mitochon-
dria have imported new (green) MitoTimer than in unstimulated cells, where
there is minimal biogenesis and correspondingly little import of newly
synthesized MitoTimer protein
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for MitoTimer in the absence of Dox; the sorted cells were
then stimulated with Dox followed by a second round of
sorting to select cells with the highest expression of
MitoTimer. The resulting cell lines exhibited tight control of
MitoTimer expression and required only a brief (2 h) pulse
with 2 mg/ml Dox in order to achieve a high level of expres-
sion. Following the pulse, it is important to completely re-
move Dox from the media by washing several times with
phosphate-buffered saline and replacing with fresh media
(and tetracycline-free serum), as even a trivial concentration
of Dox is sufficient to induce expression in cell lines selected
for high responsiveness. Utilizing the method of cell line
selection described above, we have been able to express
MitoTimer in an inducible fashion across a wide range of cell
lines; this approach is strongly recommended for in vitro
studies. MitoTimer is also a tool highly suitable for analyzing
and sorting mitochondria by flow cytometry. When used for
this purpose, it is highly recommended that single positive
green fluorescent and red fluorescent cells or mitochondria be
used in setting up the parameters of the sort to compensate for
the bleed-through of green fluorescence into the red channel.
This step is crucial in obtaining an accurate picture of the
levels of green-to-red fluorescence of individual cells and
mitochondria and should be performed alongside the
MitoTimer experiments as part of the controls.
Use of MitoTimer to investigate mitochondrial biology
We targeted Timer to the mitochondrial matrix (MitoTimer).
The rate of diffusional exchange of contents across the mito-
chondrial network is fastest for outer membrane constituents,
intermediate for matrix contents, and slowest for inner mem-
brane proteins [18]. Mitochondrial fusion events require high
membrane potential [11] and mitofusin-1 or mitofusin-2
(Mfn1/2) [34]. In cells with a normal mitochondrial network,
MitoTimer of varying degrees of maturation (green to red) is
distributed homogeneously across the network. However, in
mouse embryonic fibroblasts (MEFs) derived from Mfn1/2
double knockout mice, distribution of new vs. mature
MitoTimer was heterogeneous [34], demonstrating that fusion
events enable mixing of old and new proteins within the
mitochondrial network. Neurons also exhibit heterogeneous
distribution of MitoTimer, with newly synthesized protein
being incorporated into mitochondria closest to the soma
while mature MitoTimer predominated in the distal portion
of the neurites. In fact, the red to green ratio was proportional
to distance from the soma [34]. Interestingly, it has been
reported that autophagosomes initiate distally in neurons (near
the oldest mitochondria) and then migrate towards the soma,
where they fuse with lysosomes [41]. These examples illus-
trate the use of MitoTimer to gain spatiotemporal information
about mitochondrial age.
Use of MitoTimer to assess protein import
MitoTimer also provides information about the level of mito-
chondrial protein import across a population of cells and
organelles. High membrane potential is required for mito-
chondrial protein import [42]. Mitochondria which lose mem-
brane potential will be unable to import new (green)
MitoTimer protein. If biogenesis is impaired, one would ex-
pect a decrease in the number of mitochondria importing new
protein, which would be reflected by a decrease in green
MitoTimer in mitochondria. Conversely, increased biogenesis
would be reflected in an increase in green MitoTimer in
mitochondria. This was demonstrated in our study in which
we showed that cells recovering from FCCP or statin treat-
ment showed an increase in new MitoTimer protein import
(green mitochondria) [33] during a second period of doxycy-
cline induction (using a tetracycline-inducible construct and
rtTA-expressing cells). Using constitutive expression of
MitoTimer in a Drosophila heart tube, Laker et al. showed
that exercise training resulted in an increase in the abundance
of green mitochondria [32], consistent with increased mito-
chondrial biogenesis. Oddly, the authors attributed this green
predominance to decreased oxidative stress in the exercised
mice, although it has been shown that exercise increases
reactive oxygen species in skeletal muscle mitochondria
[43], and MitoTimer color maturation was shown to be insen-
sitive to reactive oxygen species [34]. Interestingly,
MitoTimer import during biogenesis is not uniform but is
enriched in a perinuclear zone in C2C12 cells [Fig. 2] [33]
and in neuronal cells [34]. While this may be simply due to
mRNA proximity, it is possible that the subpopulation of
mitochondria enriched for green MitoTimer is specialized
for mitochondrial regeneration.
Use of MitoTimer to assess mitochondrial turnover
Mitochondrial turnover also depends upon clearance of mito-
chondria by mitochondrial autophagy or mitophagy.
Suppression of autophagy results in the accumulation of mi-
tochondria with lower membrane potential and increased ox-
idative damage [44]. In autophagy-deficient cells in which
MitoTimer expression was induced for 4 h and allowed to
mature for 48 h, there was increased accumulation of red
MitoTimer compared to autophagy-competent cells [34], in-
dicating that mitochondrial turnover was impaired. Similarly,
in mice in which MitoTimer was constitutively expressed in
skeletal muscle (after electroporation of virus), the ratio of red
to green MitoTimer was increased in mice on a high-fat diet
compared to normal chow-fed animals; the ratio was de-
creased in mice subjected to an exercise regimen compared
to sedentary mice on the same diet [32]. Collectively, these
studies show that MitoTimer can be used to assess
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mitochondrial turnover. Analysis of mitochondrial turnover
will contribute to our understanding of disease as acquired
mitochondrial dysfunction can be compensated for through
mitophagy and biogenesis. Loss of this compensatory process
results in the accumulation of damaged mitochondria which
may generate increased reactive oxygen species; consume
ATP through reversal of the ATP synthase; disrupt calcium
homeostasis; activate innate immunity, leading to inflamma-
tion; or release cytochrome c, thereby triggering cell death.
Caveats and limitations of MitoTimer
The use of MitoTimer to date has been limited to cell culture,
with limited studies in flies and electroporation into mouse
skeletal muscle. However, the findings have engendered con-
siderable enthusiasm for the technology, and the pTRE-tight-
MitoTimer plasmid has been requested by 18 groups since it
was deposited with Addgene in April. There are some caveats
to consider when using MitoTimer, however. Given the wide
range of turnover of different proteins in mitochondria [3], it is
important to confirm that MitoTimer turnover is reflecting
mitochondrial turnover. This can be done by testing interven-
tions that either inhibit or accelerate mitophagy to confirm that
MitoTimer clearance changes accordingly. Similar verifica-
tion is needed for estimates of biogenesis. Unfortunately, the
chemical treatment used for 5-ethynyl-2′-deoxyuridine (EdU)
staining destroys fluorescent proteins, making the two mutu-
ally incompatible, although paired samples can be stained.
Nevertheless, if both protocols show the same trend, then
one can feel assured that MitoTimer is behaving as one might
expect, with respect to biogenesis. The fluorescent protein is
subject to photoconversion (green to red) by persistent light
exposure, so time-lapse imaging may not be feasible. Use in
primary cells depends upon having the appropriate viral vec-
tors for efficient gene delivery, and establishing transgenic
mice will be invaluable.
Comparison of methods to monitor mitophagy
Currently three recently introduced methods provide informa-
tion on mitochondrial turnover. The use of deuterium labeling
and mitochondrial proteome analysis is extremely powerful
and can be used in cells, non-transgenic animals, and humans
[3]. However, it provides limited subcellular information (al-
though the interfibrillar and subsarcolemmal mitochondrial
proteomes could be measured separately) and requires sophis-
ticated mass spectrometry and bioinformatics capability.
Mito-Keima is an elegant reporter for mitophagy [31] that
will become extremely useful once transgenic lines are avail-
able. Its chief limitation is that it can only report on the final
phase of mitophagy (delivery to the lysosome) and is only
applicable for fluorescence microscopy. MitoTimer provides
information on biogenesis and, by using time-restricted ex-
pression, can also provide information on mitophagy [33].
Constitutive expression of MitoTimer can provide informa-
tion on the relative balance of mitophagy and biogenesis [32,
34]. Currently the approach is limited to cell culture or elec-
troporation into tissues; however, adenoviral delivery to the
heart is feasible, as is production of a transgenic mouse with
either the tetracycline-inducible promoter or a constitutive
promoter. Mitochondrial biogenesis can also be monitored in
cells or in vivo by incorporation of tagged nucleotides such as
BrdU or EdU into mitochondrial DNA; successful labeling of
mtDNAwas described by Oka et al. [45].
Conclusions
Impaired mitochondrial quality control is frequently a conse-
quence of impaired autophagy in conditions such as advanced
age or the metabolic syndrome. Loss of mitochondrial quality
control may contribute to many chronic disease phenotypes. The
use of MitoTimer to monitor mitochondrial turnover may reveal
new insights into mitochondrial biology in health and disease.
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